Home
Teikoku Seiyaku Co

Teikoku Seiyaku Co Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainteikoku.co.jp

Year Founded1848

Employees501 - 1000

Annual Revenue$100M - $200M

Teikoku Seiyaku Co

Teikoku Seiyaku Co (including company regionals)

teikoku.co.jp

See more website traffic and engagement information

Teikoku Seiyaku Co Revenue up to November 2025 is 100M - 200M

revenue generated by Teikoku Seiyaku Co top domains

Teikoku Seiyaku Co top domains revenue over 3 years

Revenue for Teikoku Seiyaku Co top domains

teikoku.co.jp100M - 200M

See more with Sales Intelligence

Total visits to Teikoku Seiyaku Co's top domains

Understand Teikoku Seiyaku Co market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

teikoku.co.jp17.4K

See more with Sales Intelligence

Avg. visit duration in Teikoku Seiyaku Co's top domains

Analyze Teikoku Seiyaku Co engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

teikoku.co.jp00:01:26

See more with Sales Intelligence

Avg. pageviews on Teikoku Seiyaku Co's top domains

See how Teikoku Seiyaku Co keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

teikoku.co.jp2.65

See more with Sales Intelligence

Teikoku Seiyaku Co top competitors by domain

Top similar sites in November 2025, ranked by their affinity

teikoku-drugstore.co.jpCompany Name短時間睡眠に必要な事は？無理して短時間睡眠するのはやめましょう！ | 株式...Employees51 - 200HQJapanAnnual revenue--Total visits4.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Teikoku Seiyaku Co

looks like we dont have enough data

No Data to Display

News & Signals from Teikoku Seiyaku Co

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTeikoku Seiyaku Co., Ltd. recognized as Global Niche Top Companies Selection 100 in FY 2020 on Jun 30th '20.Teikoku Seiyaku Co., Ltd. (Headquarters: Kagawa, Japan (President and CEO: Misako Fujioka) was selected as one of the ‘Global Niche Top Companies Selection 100 in FY 2020’ by The Ministry of Economy, Trade and Industry of Japan (METI) on June 30th, 2020.

NewsTeikoku Seiyaku Co., Ltd. partnered with ReqMed Company, Ltd. on Dec 19th '25.For osteoarthritis, Teikoku Seiyaku has entered into a basic sales agreement with ReqMed Company, Ltd. regarding exclusive distribution rights in Japan for a subcutaneous injection containing NaPPS (sodium pentosan polysulfate), which is currently in Phase 3 clinical trials in Japan.